Haystack Oncology
Latest round
- Series A
Last raised
- Oct 2022
Total raised
- $67M
Investors
- 4
About Haystack Oncology
Based in Maryland, US, and founded in 2021 by Bert Vogelstein, Kenneth Kinzler, and Nick Papadopoulos, Haystack Oncology is a biotechnology research firm that detects circulating tumor DNA in order to identify the lowest levels of ctDNA in blood to report residual, recurrent or resistant disease. The company uses liquid biopsy technologies to detect the presence of traces of residual tumor DNA molecules left in the body after the initial treatment to help predict the recurrence of the disease. Haystack's testing is intended to inform clinical interventions by developing personalized diagnostic panels regardless of tumor origin.
Who invested in Haystack Oncology
4 investors across 1 round
See all investors in Haystack Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 17, 2022
Amount
$67M
Investors
Questions about Haystack Oncology
Who invested in Haystack Oncology?
Haystack Oncology has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haystack Oncology raised?
Haystack Oncology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Haystack Oncology last raise money?
Haystack Oncology's most recent round on record is a Series A, in Oct 2022.
What does Haystack Oncology do?
Based in Maryland, US, and founded in 2021 by Bert Vogelstein, Kenneth Kinzler, and Nick Papadopoulos, Haystack Oncology is a biotechnology research firm that detects circulating tumor DNA in order to identify the lowest levels of ctDNA in blood to report residual, recurrent or resistant disease.
Where is Haystack Oncology headquartered?
Haystack Oncology is headquartered in Baltimore, US.
Which VCs invest in companies like Haystack Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Haystack Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Haystack Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.